Celera Corporation Fourth Quarter and Fiscal 2008 Results and Conference Call Scheduled for July 23, 2008
Celera Corporation (NASDAQ:CRA) announced today that it will issue fourth quarter and fiscal 2008 financial results on Wednesday, July 23, 2008. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy Ordonez, Chief Executive Officer, and Joel Jung, Chief Financial Officer, will lead a conference call the same day at 4:30 p.m. (ET) to discuss these results and other matters related to the business.
The management team will make prepared remarks and answer questions from securities analysts and investment professionals. Investors, securities analysts, representatives of the media and other interested parties who would like to participate should dial 888.396.2386, or 617.847.8712 for international callers, and enter passcode 82911269 at any time from 4:15 p.m. (ET) until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the “Investors & Media” section on www.celera.com. A digital recording will be available approximately two hours after the completion of the conference call on July 23 until August 7, 2008. Interested parties should call 888.286.8010, or 617.801.6888 for international callers, and enter passcode 31506190.
About Celera
Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and optimize patient management. Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.celera.com.
Forward-Looking Statements
Some statements contained in, or incorporated by reference in, this press release are forward-looking and are subject to a variety of risks and uncertainties. These forward-looking statements may be identified by the use of forward-looking words or phrases such as “believe,”"expect,”"intend,” and “anticipate,” among others. The forward-looking statements contained in this press release are based on our current expectations, and those made at other times will be based on our expectations when the statements are made. We cannot guarantee that any forward-looking statements will be realized.
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. To comply with the terms of the safe harbor, we note that a variety of factors could cause actual results and experience to differ materially from anticipated results or other expectations expressed in forward-looking statements. We also note that achievement of anticipated results or expectations in forward-looking statements is subject to the possibility that assumptions underlying forward-looking statements will prove to be inaccurate. Investors should bear this in mind as they consider forward-looking statements. The risks and uncertainties that may affect the operations, performance, development, and results of our business include, but are not limited to, those described under the heading “Risks Factors” our Registration Statement on form S-1 declared effective by the Securities and Exchange Commission on June 19, 2008. We note that our business could be affected by other factors that we have not disclosed because we think they are immaterial. Also, there may be additional risks and uncertainties that could affect our businesses but which are not currently known to us.
Copyright(C) 2008. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.